Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Medicine and Dentistry
Omega-3 Fatty Acid
85%
Insulin Resistance
64%
Lipid
57%
Supplementation
45%
Maturity Onset Diabetes of the Young
42%
Gene Expression
42%
Dyslipidemia
38%
Triacylglycerol
30%
FGF21
28%
White Adipose Tissue
28%
Lactic Acid
28%
Comorbidity
28%
High Fat Food
28%
In Vitro
28%
Polyphenol
28%
Nutritional Intervention
28%
Placebo
28%
Hypertriglyceridemia
28%
Therapeutic Target
28%
Lipogenesis
28%
Obesity Management
28%
Obesity
28%
Oximetry
23%
Blood Sampling
19%
Cardiometabolic Risk
19%
Lipid Metabolism
16%
Inflammation
16%
High Intensity Interval Training
14%
Subcutaneous White Adipose Tissue
14%
Fatty Acid Oxidation
14%
Receptor Family
14%
Liver X Receptor
14%
Cell Nucleus Receptor
14%
Leucine Zipper Protein
14%
Fatty Liver
14%
Diet Induced Obesity
14%
down Regulation
14%
Liver Metabolism
14%
Nonalcoholic Fatty Liver
14%
Insulin Response
14%
Heterodimer
14%
Moderate-Intensity Continuous Training
14%
Body Fat
9%
Blood Pressure Measurement
9%
Systolic Blood Pressure
9%
Very Low Density Lipoprotein
9%
Clinical Trial
9%
Bed Rest
9%
Metabolic Syndrome
9%
Cardiovascular Disease
9%
Biochemistry, Genetics and Molecular Biology
Insulin Resistance
66%
Omega 3 Fatty Acid
59%
Omega-3 Fatty Acid
57%
Metabolic Pathway
57%
Isoform
57%
Adiponectin
57%
High Intensity Interval Training
47%
Gene Expression
42%
Maturity Onset Diabetes of the Young
42%
FGF21
33%
Triglyceride
33%
Comorbidity
31%
Lipid
28%
Dyslipidemia
28%
Triacylglycerol Blood Level
28%
Lipogenesis
28%
Corepressor
28%
Triacylglycerol Level
23%
Eicosapentaenoic Acid
16%
Molecular Weight
15%
Liver X Receptor
14%
Insulin Response
14%
Liver Metabolism
14%
Downregulation
14%
Leucine Zipper
14%
Nuclear Receptor
14%
Mouse Mutant
14%
Beta Oxidation
14%
Molecular Mechanism
14%
Glucoside
14%
Lipid Metabolism
11%
Global Health
9%
Prevalence
9%
Kallikrein
9%
Controlled Clinical Trial
9%
Kinin-Kallikrein System
9%
Insulin Signaling
9%
Peroxisome Proliferator-Activated Receptor
9%
Sterol Regulatory Element Binding Protein 1c
9%
Body Fat Distribution
9%
Cooperation
9%
Fibroblast Growth Factor Receptor
7%
Docosahexaenoic Acid
7%
Gene Expression Profiling
7%
Randomized Controlled Trial
7%
Oxidative Stress
7%
Genetic Divergence
7%
Intestine Flora
7%
Mann-Whitney U Test
5%
Western Blot
5%
Immunology and Microbiology
Fatty Acid
100%
Insulin Resistance
66%
Inflammation
59%
Adiponectin
57%
Lipid Metabolism
54%
Cardiovascular System
52%
High Intensity Interval Training
47%
Subcutaneous White Adipose Tissue
42%
Triacylglycerol Blood Level
32%
White Adipose Tissue
28%
Adipose Tissue
28%
Gut Microbiome
28%
Blood Sampling
28%
Mouse Mutant
28%
Triacylglycerol Level
23%
Protein Binding
19%
Thermogenesis
19%
Acetic Acid Derivative
16%
Glycoprotein
16%
Inflammation Response
16%
Molecular Weight
15%
Body Fat
14%
Morbidity
14%
Liver Metabolism
14%
Leucine
14%
Systolic Blood Pressure
14%
Blood Pressure
14%
Body Composition
14%
Waist Hip Ratio
14%
Fibroblast Growth Factor 21
14%
Gene Expression
11%
Lactobacillus
11%
Global Health
9%
Peroxisome
9%
Kallikrein Kinin System
9%
Prevalence
9%
Insulin Signaling
9%
Sterol Regulatory Element Binding Protein 1c
9%
Body Fat Distribution
9%
Synergism
9%
Lipogenesis
9%
Repressor Gene
9%
Fatty Acid Oxidation
9%
Comorbidity
9%
DNA Responsive Element
9%
Adenoviridae
9%
Glucose Level
9%
Insulin Response
9%
Insulin Level
9%
